The pooled prevalence of primary sclerosing cholangitis (PSC) is 2.16 percent in patients with inflammatory bowel disease (IBD), according to a review published in the December issue of Gastroenterology.
Source: Medicalxpress
The pooled prevalence of primary sclerosing cholangitis (PSC) is 2.16 percent in patients with inflammatory bowel disease (IBD), according to a review published in the December issue of Gastroenterology.
Source: Medicalxpress